Clinical Trials Directory

Trials / Completed

CompletedNCT03503214

Non Carbonic Buffer Power of Critical Ill Patients With Sepsis

Changes in Acid-base Variables Induced by Acute Variations in Partial Pressure of Carbon Dioxide in Whole Blood and Isolated Plasma of Septic Critically Ill Patients and Healthy Volunteers: an In-vitro Study

Status
Completed
Phase
Study type
Observational
Enrollment
36 (actual)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Alterations of acid-base equilibrium are very common in critically ill patients and understanding their pathophysiology can be important to improve clinical treatment. The human organism is protected against acid-base disorders by several compensatory mechanisms that minimize pH variations in case of blood variations in carbon dioxide content. The aim of the present study is to quantify the buffer power, i.e. the capacity to limit pH variations in response to carbon dioxide changes, in critically ill septic patients and compare these results with data collected from healthy volunteers.

Detailed description

Alterations of acid-base equilibrium are very common in critically ill patients and understanding their pathophysiology can be important to improve clinical treatment. The human body is protected against acid-base disorders by several compensatory mechanisms that minimize pH variations in response to acid-base derangements. The present study focuses on the acute compensatory mechanisms of respiratory acid-base derangements, i.e., respiratory acidosis and respiratory alkalosis. In this case the non-carbonic buffers are constituted by albumin and phosphates in plasma, with the addition of hemoglobin in whole blood. Aim of the present in-vitro study is to measure the buffer power of non-carbonic weak acids contained in whole blood and isolated plasma, assess the relative contribution of red blood cells and plasma proteins and perform a comparison between septic patients and healthy controls.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTIn vitro determination of non-carbonic buffer powerIn vitro measurement of the non-carbonic buffer power by the means of equilibration of whole blood and isolated plasma with gas mixtures containing different concentrations of carbon dioxide
DIAGNOSTIC_TESTClassic description of acid-base statusMeasurement of plasma electrolytes, hemoglobin concentration, albumin and phosphates to compute acid-base variables according to Stewart's approach.

Timeline

Start date
2018-03-07
Primary completion
2019-02-20
Completion
2019-02-20
First posted
2018-04-19
Last updated
2019-04-25

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03503214. Inclusion in this directory is not an endorsement.